Métastases mammaires des cancers bronchopulmonaires avec mutation de l'EGFR

In patients with lung adenocarcinoma and EGFR mutation, immunohistochemical examination, including TTF1 and genotyping of synchronous breast tumour, is needed to confirm its metastatic nature and to guide treatment.